12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements in Friday's after-market session, with Biofrontera, Tivic Health Systems, Evelo Biosciences, Cano Health, Navidea Biopharmaceutical, and CalciMedica among the gainers, while Oncorus, SCWorx, Mallinckrodt, Accelerate Diagnostics, Perspective Therapeutics, and IMAC Hldgs were the losers.
June 16, 2023 | 9:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Accelerate Diagnostics' shares declined 7.06% to $0.76.
Accelerate Diagnostics' significant price decrease suggests strong selling pressure, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
IMAC Hldgs' shares decreased 6.77% to $0.13.
IMAC Hldgs' significant price decrease suggests strong selling pressure, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Perspective Therapeutics' shares declined 6.84% to $0.66.
Perspective Therapeutics' significant price decrease suggests strong selling pressure, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Mallinckrodt's shares declined 7.82% to $1.18, with trading volume reaching 9.1% of its 100-day average.
Mallinckrodt's significant price decrease suggests strong selling pressure, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Oncorus' stock fell 15.7% to $0.11 during Friday's after-market session, with trading volume reaching 2994.7% of its 100-day average.
Oncorus' significant price decrease and high trading volume indicate strong selling pressure, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
SCWorx's shares fell 14.39% to $0.54, with trading volume reaching 130.5% of its 100-day average.
SCWorx's significant price decrease and above-average trading volume suggest strong selling pressure, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Biofrontera's shares surged 52.3% to $0.67 during Friday's after-market session, with trading volume reaching 2335.8% of its 100-day average.
Biofrontera's significant price increase and high trading volume indicate strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
CalciMedica's shares rose 12.32% to $5.65.
CalciMedica's significant price increase suggests strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Cano Health's stock rose 15.94% to $1.45, with trading volume reaching 27.5% of its 100-day average.
Cano Health's significant price increase and above-average trading volume suggest strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Evelo Biosciences' shares increased 23.26% to $0.16, with trading volume reaching 1296.6% of its 100-day average.
Evelo Biosciences' significant price increase and high trading volume indicate strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Navidea Biopharmaceutical's shares increased 12.99% to $0.1, with trading volume reaching 352.6% of its 100-day average.
Navidea Biopharmaceutical's significant price increase and high trading volume indicate strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Tivic Health Systems' shares rose 26.7% to $0.12, with trading volume reaching 112.0% of its 100-day average.
Tivic Health Systems' significant price increase and above-average trading volume suggest strong investor interest, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100